Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Kan-Jang® Supplementation in Patients Diagnosed With COVID-19: A Randomized, Quadruple-blind, Placebo-controlled Trial

NCT04847518 is registered in ClinicalTrials.gov with Swedish Herbal Institute AB as lead sponsor.

NCT NCT04847518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04847518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Kan-Jang® Supplementation in Patients Diagnosed With COVID-19: A Randomized, Quadruple-blind, Placebo-controlled Trial
Lead sponsor
Swedish Herbal Institute AB
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 26, 2021
Completion date
March 31, 2022
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19